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BLOKLAND, A. AND J. JOLLES. Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV 
injection of streptozotocin. PHARMACOL BIOCHEM BEHAV 44(2) 491-494, 1993.-ICV injections of streptozotocin 
(STREP) lower the glucose utilization of the brain and affect the cholinergic system. The present study was designed to 
evaluate whether STREP-treated rats have an impaired spatial discrimination performance in the Morris spatial navigation 
task. Performance in this task is sensitive to treatment with cholinergic antagonists. In contrast to young rats, middle-aged 
STREP-treated rats tended to have an impaired spatial discrimination performance in the Morris task at the end of training. 
In middle-aged STREP-treated rats, but not in control rats, spatial discrimination performance was associated with hippocam- 
pal choline acetyltransferase (CHAT) activity. The correlation between spatial discrimination performance in the Morris task 
and the decrease in hippocampal ChAT activity resembles the relation between cognitive and biochemical changes observed 
in Alzheimer's disease. Our findings suggest that STREP treatment of middle-aged rats may provide a relevant model for 
dementia. 
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RECENTLY, Hoyer and coworkers (10,12,13) introduced a 
model in which brain glucose metabolism is decreased by an 
ICV injection of streptozotocin (STREP). An ICV injection 
of STREP impairs the brain insulin-insulin receptor system 
and consequently leads to a decrease in brain glucose utiliza- 
tion (12). It has been reported that a reduced brain glucose 
utilization is related to the age-related decline in cognitive 
function (7,19). A more dramatic decrease in glucose utiliza- 
tion has been observed in dementia (4), suggesting that the 
severity of cognitive dysfunction is related to the level of brain 
glucose metabolism. So far, the effects of an ICV STREP- 
injection on cognition have only been evaluated in inhibitory 
avoidance learning, where STREP-treated rats show an im- 
paired performance, possibly as a result of a cholinergic dys- 
function (10). This explanation is supported by the finding 
that the level of choline acetyltransferase (CHAT) in the brain 
is reduced in STREP-treated rats [see (12)]. 
Spatial discrimination learning has consistently been found 
to decline with aging (2,16) and be impaired after administra- 
J To whom requests for reprints should be addressed. 
tion of cholinergic antagonists (9,17). It can thus be hypothe- 
sized that ICV STREP-treated rats will also show a deficit in 
spatial discrimination learning. It has recently been reported 
that spatial discrimination learning is impaired in patients with 
Alzheimer's disease, which suggests that the cognitive deficits 
displayed by Alzheimer's patients might be an expression of 
an underlying abnormality in the hippocampus and parietal 
cortex (1). Further, the decline in cognitive functions in Alz- 
heimer's disease is related to a decrease in cholinergic markers 
(8,15). Thus, evaluation of the effects of STREP treatment on 
spatial discrimination learning and cholinergic activity could 
reveal whether the STREP-treated rat can be regarded as an 
animal model of dementia. 
The aim of our study was to evaluate the effects of STREP 
on spatial discrimination learning in the Morris task. We also 
subjected rats to an inhibitory avoidance task 1 week after 
training in the Morris task to evaluate whether we could repro- 
duce the findings of Mayer et al. (10). The behavioral data 
were correlated with hippocampal ChAT activity. 
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EXPERIMENT 1 
M E T H O D  
Animals and Surgery 
We used 15 4-month-old male Lewis rats, randomly as- 
signed to the control group (CON; n = 7) or the STREP 
group (n = 8). All rats were housed individually in standard 
Makrolon cages on sawdust bedding in an air-conditioned 
room (about 20"C). They were kept under a 12 L : 12 D cycle 
(lights on from 0900-2100 h). 
One week before behavioral testing, rats were anesthetized 
with pentobarbital (60 mg/kg, IP) and placed in a stereotaxic 
frame. The STREP group was given a bilateral ICV injection 
of STREP (1.5 mg/kg body weight dissolved in 4/~1 saline, 2 
/zl/injection site). The stereotaxic coordinates were: - 0 . 8  mm 
anterior, 1.5 mm lateral, and - 3.8 ventral from bregma (14). 
The CON group underwent the same surgical procedures but 
saline was injected instead of STREP. 
Behavioral Procedures 
Ten days after surgery, rats were trained on the standard 
Morris spatial navigation task (11) in a black water tank (di- 
ameter 1.22 m). Rats were started from four different, ran- 
domly chosen, start positions and trained to find an invisible 
platform (diameter 11 cm) at a fixed position in the water 
tank, 1 cm below the surface of the water. The temperature 
of the water was 20-22°C. A trial lasted until a rat had found 
the platform or until 60 s had elapsed. If a rat did not find the 
platform within 60 s, it was placed on the platform for 3 s 
and then removed from the water tank. On the first day, rats 
were given four trials. They were given eight trials on the next 
day and 4 trials on the third day. 
Four days after acquisition of the Morris task, rats were 
subjected to the inhibitory avoidance task. The inhibitory 
avoidance apparatus consisted of a light and a dark compart- 
ment, each measuring 40 × 25 × 40 cm. The light compart- 
ment was illuminated by a light bulb (60 W) mounted above 
(40 cm) the compartment. The floor consisted of a metal grid 
connected to a shock scrambler. The two compartments were 
separated by a guillotine door that could be raised 10 cm. On 
day 1, rats were placed in the light compartment and the la- 
tency to enter the dark compartment with four paws was mea- 
sured. The guillotine door was lowered and a scrambled foot- 
shock (0.5 s, 1 mA) was delivered. Twenty-four hours later, a 
retention trial was given. The latency to enter the dark com- 
partment with four paws was measured. 
Statistical Analysis 
The step-through latency in the 24-retention session minus 
the step-through latency during the first trial was taken as the 
parameter for inhibitory avoidance performance. Treatment 
effects were evaluated using a t-test. For analysis of the Morris 
task data, the mean escape latency was calculated per block of 
four trials. Treatment effects were evaluated in a two-factorial 
(treatment and trial block) analysis of variance (ANOVA) 
with repeated measures over trial blocks. 
R E S U L T S  A N D  C O N C L U S I O N S  
STREP treatment did not affect the step-through latency 
during the first trial [step-through latency in seconds (SEM): 
CON, 9.6 (2.67); STREP, 12.9 (3.67); t(13) = 1.14, p > 
0.10]. Corroborating the findings of Mayer et al. (10), we 
found that inhibitory avoidance performance was impaired in 
STREP-treated rats [difference score in seconds (SEM): CON, 
234.0 (35.65), STREP, 113.3 (39.30); t (13)= 2.28, p < 
0.05]. 
In the Morris task, the escape latency of the rats decreased 
during training, F(3, 39) = 39.27, p < 0.01 (see Fig. 1), and 
the escape latency of the STREP group was higher during the 
acquisition of the task [general mean, F(I,  13) = 8.54, p < 
0.05]. During the last trial block, the performance of CON 
and STREP-treated rats did not differ, t(13) = 0.67, p < 
0.10. Treatment with cholinergic antagonists results in an im- 
paired spatial discrimination performance at the end of train- 
ing (17). The STREP-induced performance deficit was there- 
fore not comparable to the pattern normally observed in rats 
treated with cholinergic antagonists. Because no behavioral 
deficit was found in STREP-treated rats at the end of training, 
hippocampal ChAT activity was not determined. We assumed 
that young rats are able to reverse/compensate for the effects 
of STREP treatment. 
EXPERIMENT 2 
M E T H O D  
Animals and Surgery 
We used 16 17-month-old male Lewis rats, randomly as- 
signed to the control group (CON; n = 8) or the STREP 
group (n = 8). Housing conditions and surgical procedures 
were identical to those of Experiment 1. One STREP-treated 
rat died during training for unknown reasons. 
Behavioral Procedures 
Behavioral procedures were identical to those of Experi- 
ment 1. However, in this experiment rats were given 4 trials 
on the first day and 8 trials on each of the next 3 days to a 
total of 28 trials. 
ChAT A ctivity 
One week after training (3 weeks after ICY injection with 
STREP), rats were decapitated and heads were immediately 
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FIG. l. Escape latencies (in seconds + SEM) of 4-month-old con- 
trol ((3) and streptozotocin-treated (Q) Lewis rats during acquisition 
of the Morris spatial navigation task. 
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immersed in liquid nitrogen for 8 s. Brains were taken out of 
the skull and the hippocampus was dissected at 0-4°C. Tissue 
samples were stored at - 8 0 ° C  until used to measure ChAT 
activity. Brain samples were homogenized (5°70) in 50 mM 
phosphate buffer (pH 7.4) containing 0.2% Triton X-100 and 
20 mM EDTA (pH 7.4). ChAT activity was determined ac- 
cording to the method of Fonnum (6), using [14Clacetyl coen- 
zyme-A (Amersham Corp., Arlington Heights, IL, 50-60 
mCi/mM). 
Statistical Analysis 
Analysis of the Morris task and inhibitory avoidance data 
was identical to that of Experiment 1. Interdependencies of 
the different measures were analyzed using Pearson's correla- 
tion coefficient. 
R E S U L T S  A N D  C O N C L U S I O N S  
STREP treatment did not affect the step-through latency 
during the first trial [step-through latency in seconds (SEM): 
CON, 29.8 (4.40); STREP, 27.0 (8.60); t(13) = 0.29, p > 
0.10] and there was no treatment effect on inhibitory avoid- 
ance learning [difference score in seconds (SEM): CON, 229.4 
(98.42); STREP, 158 (87.31); t(13) = 0.53,p > 0.10]. 
Analysis of the data for the acquisition of the Morris task 
revealed that rats reduced their escape latencies during train- 
ing, F(6, 78) = 14.07, p < 0.01 (see Fig. 2) and that STREP- 
treated rats tended to have a poorer performance than control 
rats [general mean, F(1, 13) = 3.74, 0.10 > p > 0.05]. 
Hippocampal ChAT activity (nM/mg protein/h) was de- 
creased in STREP-treated rats [mean (SEM): CON, 83.6 
(1.24); STREP, 45.0 (12.27); t(13) = 9.03,p < 0.01]. 
There was no correlation between inhibitory avoidance per- 
formance and hippocampal ChAT activity for either the CON 
or STREP group (r = 0.20 and -0 .41 ,  respectively; for both 
correlations, p > 0.10). However, hippocampal ChAT activ- 
ity correlated negatively with the mean escape latency of the 
STREP group during the last four trial blocks of training in 
the Morris task, where the mean escape latency of the CON 
and STREP group diverged (r = -0 .86 ,  p < 0.05; see Fig. 
3). No correlation between the two measures was found for 
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FIG. 2. Escape latencies (in seconds + SEM) of 17-month-old con- 
trol (©) and streptozotocin-treated (0) Lewis rats during acquisition 
of the Morris spatial navigation task. 
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FIG. 3. Relation between hippocampai choline acetyltransferase ac- 
tivity (riM/rag protein/h) and average escape latency during the last 
four trial blocks of training in the Morris task for 17-month-old con- 
trol ((3) and streptozotocin-treated (0) Lewis rats. 
the CON group (r -- -0 .22,  n.s.). Low hippocampal ChAT 
activity thus predicted poor swimming performance in the 
Morris task in STREP-treated rats. 
GENERAL DISCUSSION 
The present study showed that STREP treatment affected 
spatial discrimination performance in the Morris task at the 
end of training in middle-aged rats but not in young rats. This 
performance deficit of middle-aged STREP-treated rats was 
correlated with a decrease in hippocampal ChAT activity. 
Such a relation between spatial discrimination learning and 
the (hippocampal) cholinergic system has been found in other 
studies (3,9,18). 
In contrast to the study of Mayer et al., in which 12-month- 
old Wistar rats were used (10), we did not observe a STREP- 
induced impairment in inhibitory avoidance learning in mid- 
die-aged rats. However, it should he mentioned that the mean 
difference score was higher for CON rats than for STREP 
rats but that the variation in both experimental groups was 
high. This large within-group variation may be due to the age 
of rats used in the present experiment (see also below). An- 
other explanation for the different results could be that there 
were differences in the strain of rats used, apparatus, and 
parameters used in the inhibitory avoidance task. 
An ICV injection of STREP in 3-month-old rats did not 
lead to a spatial discrimination performance deficit similar to 
that of rats treated with cholinergic antagonists. We assume 
that young rats are able to reverse/compensate for the effects 
of STREP treatment. However, young STREP-treated rats 
showed an impaired inhibitory avoidance performance, 
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thereby corroborating the results of Mayer et al. (10), who 
assumed that the shorter step-through latency during the test 
trial in the inhibitory avoidance task was not attributed to the 
STREP-induced increase in spontaneous locomotor activity 
because the step-through latency in the first trial did not differ 
for the STREP and control groups. It could, however, be 
argued that the STREP-induced increase in spontaneous loco- 
motor activity might not be detected during the first trial be- 
cause both the control and STREP groups had a short initial 
step-through latency. In the test trial, the STREP-induced in- 
crease in spontaneous locomotor activity could have decreased 
the step-through latency. These data should therefore be inter- 
preted with caution. The absence of a STREP-induced learn- 
ing impairment in the Morris task in young rats underscores 
the possibility that inhibitory avoidance learning in young 
STREP-treated rats is affected by an increase in spontaneous 
locomotor activity. Because inhibitory avoidance learning was 
not affected by STREP treatment in middle-aged rats, it is 
unlikely that the impaired spatial discrimination performance 
of  these rats was affected by STREP-induced increase in spon- 
taneous locomotor activity. 
An ICV injection of STREP affects not only the choliner- 
gic system but also the concentration of different monoami- 
nergic neurotransmitters (noradrenaiine, dopamine, and sero- 
tonin) in the rat brain differently (5). It could be argued that 
a change in these neurotransmitter systems could also have 
affected spatial discrimination performance in the Morris 
task. However, in the present study we found a strong correla- 
tion between escape performance and hippocampal ChAT ac- 
tivity, which suggests that there is a relation between the two 
measures. Such a correlation between cognitive function and 
ChAT activity has also been found in Alzheimer's disease 
(8,15). In addition, it has been found that, apart from the 
marked decrease in acetylcholine, Alzheimer's disease is ac- 
companied by changes in different monoaminergic neuro- 
transmitter systems [see (5)]. Thus, there is a resemblance in 
the decline in monoaminergic transmitter functions and a re- 
semblance in relation between cholinergic function and cogni- 
tive processes in middle-aged STREP-treated rats and Alzhei- 
mer's disease. This observation suggests that the middle-aged 
STREP-treated rat can be regarded as an animal model for 
the cognitive decline observed in dementia. 
Further, it has been suggested that the impairment of car- 
bohydrate and related amino acid metabolism in Alzheimer's 
disease is related to an impairment of the insulin-insulin re- 
ceptor system, also affected by ICV-administered STREP 
(13). A similar dysfunction of an underlying fundamental bio- 
chemical process may explain the similarities between the bio- 
chemical and cognitive changes in Alzheimer's disease and in 
the middle-aged STREP-treated rat. The present results en- 
courage further investigation of the effects of STREP at both 
a behavioral and biochemical level. 
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